ClinicalTrials.Veeva

Menu
N

Nebraska Hematology-Oncology | Lincoln, NE

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY2835219
Abemaciclib
Pembrolizumab
Bendamustine
Idelalisib
BNT327

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer (MONARCH 3)

The main purpose of this study is to evaluate how effective nonsteroidal aromatase inhibitors (NSAI) plus abemaciclib are in postmenopausal women wit...

Active, not recruiting
Breast Cancer
Drug: Abemaciclib
Drug: Anastrozole

This is a Phase III, multisite, randomized, double-blinded study to investigate BNT327 combined with chemotherapy (etoposide/carboplatin) compared to...

Enrolling
Extensive-stage Small-cell Lung Cancer
Drug: BNT327
Drug: Carboplatin

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have previously received treatment with...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib
Drug: Bendamustine

Trial sponsors

Lilly logo
BioNTech logo
Loxo Oncology logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems